Why is Solvay stock sliding today?
Solvay (SOLB) stock fell 4.2% to €23.86 after reporting Q3 2026 EBITDA of €173M, below consensus. The company cut full-year EBITDA guidance to €720-740M and free cash flow to €120-150M. Analysts reduced price targets, citing geopolitical disruptions and earnings concerns. The stock hit a 52-week low of €22.58.
How this was made
The 30-second read
Why it matters
The earnings miss and guidance cut triggered a 4.2% intraday decline, with analysts trimming price targets, indicating heightened downside risk.
Market read
The news directly impacts Solvay's share price and may influence sentiment across European chemicals stocks.
What to watch
Potential upside from cost‑cutting measures or recovery at the Sadara plant could mitigate the impact.
Background
Solvay's Q3 results were below consensus, driven by a shutdown at its Sadara joint‑venture plant in Saudi Arabia and broader Middle‑East conflict impact.
Market effects
European specialty chemicals sector may see broader pressure as Solvay's miss highlights regional demand and geopolitical risks.
Belgian BEL 20 underperforms the broader European market due to Solvay's decline.
Limited; primarily affects European chemicals and investors with exposure to Solvay.
Counterpoint
If the market overreacts, the lower guidance could be a buying opportunity for long‑term investors.
Key entities
- CompanySolvay
Belgian specialty chemicals group (ticker SOLB).
- AnalystJPMorgan
Maintained Overweight rating but lowered price target.
- AnalystKBC
Reduced price target from €27 to €23.
